Clinical Registry on Sudden Death Primary Prevention at Latin America (ESCAPE-ICD)
Clinical Registry on Sudden Death Primary Prevention at Latin America (rEgiStro Clinico en America Latina de Prevencion Primaria en muErte Subita)
INTRODUCTION: Sudden cardiac death is one of the most important reasons of death at industrialized countries. Despite its importance, nowadays Clinical Guidelines are not as extended as expected, with respect to indications for primary prevention defibrillator implantation, following MADIT II and MUSTT criteria, especially at Latin American countries.
OBJECTIVES: This Project is designed with the purpose of providing tools to help spreading primary prevention by the means of clinical evidence on real risk of death in this group of patients.
REGISTRY DESIGN:
- retrospective (at stage 1); prospective (at stage 2)
- multi-center (minimum 25-30 centres)
- international (Argentina, Brazil, Colombia, Chile, Mexico and Venezuela)
- non randomized.
- Sample size: at screening about 12.500 patients and 962 patients at treatment stage
REGISTRY DEVICES: CE marked (Conformité Européenne) single-chamber, dual-chamber or CRT (Cardiac Resynchronization Therapy) implantable cardiac defibrillator (ICD).
연구 개요
상세 설명
REGISTRY STAGES 2 stages will be performed:
- Stage 1 (Screening): 12500 patients with MI and LVEF<40% will be evaluated, to know ICD implantation prevalence in such patients at Latin American countries
- Stage 2 (Treatment): after patient screening and as per clinical decision, 962 patients will be entered in group 1 and 2 (481 each, 1:1)
STEERING COMMITTEE
- Dr. Sergio Dubner. Clinica y Maternidad Suizo Argentina and De Los Arcos Sanatorio. Buenos Aires - Argentina
- Dr. William Uribe. CES CARDIOLOGIA. Medellin - Colombia
CLINICAL ASSESSMENT
• Dr Francisco Javier Alzueta Rodriguez. Hospital Clinico Universitario Virgen de la Victoria. Malaga - Spain
REGISTRY DURATION
- Patient enrollment period initiation: September 2011
- End of patient enrollment: September 2013
- End of FUs: September 2018
- Registry closure and data analyses: 4Q 2018.
REGULATORY CONSIDERATIONS As this is an observational registry, no submission to National Authorities is required.
연구 유형
연락처 및 위치
연구 장소
-
-
-
Tucuman, 아르헨티나
- Centro Privado de Cardiología
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- Patients that had Acute Myocardial Infarction (>40 days post-AMI) documented with the presence of Q-wave or cardiac-specific enzymatic markers of myocardial necrosis (CK-MB/troponin), occurred within 3 years previous to enrollment / after June 2008.
- Left Ventricular Ejection Fraction (LVEF) ≤40% post-revascularization (if no revascularization, measurement performed <3 months previous to patient enrollment, >40 days post-AMI and >3 months post-revascularization -if applicable-).
Exclusion Criteria:
- Patient with an implanted ICD
- <18 years old
- Pregnant or breast feeding women
- Patients that are already participating in other Investigational Study or Registry
- Non signed patient informed consent or refusal from patient's reference physician to patient participation
- Patient inability to comply with protocol (assist to scheduled follow-ups), due to: residence displacement out of center's activity area; unstable geographical situation or at very long distance from the center; unstable medical and/or psychological condition
- Cardiac transplanted (or in transplant waiting list)
- Severe Heart Failure (or other co-morbidity: cancer, renal failure, etc.)
- Life expectancy lower than 1 year
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
ICD implantation
Patients that receive an ICD implantation (non randomized, by clinical decision) will enter this group
|
Standard ICD implantation (as per clinical decision)
다른 이름들:
|
|
Non ICD implantation
Patients that do not receive ICD implantation (non randomized, by clinical decision); they can receive any other treatment (e.g.
antiarrhythmic drugs)
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Prevalence of patients with MADIT, MADIT II and MUST at Latin American countries
기간: Patients that suffered from MI in the last 3 years and during the enrollment period
|
Primary Outcome at Stage 1: Determine prevalence of patients with myocardial infarction and high risk of sudden death at Latin America, that fulfill inclusion criteria Primary Outcome at Stage 2: Compare MACE development in patients that receive ICD implantation vs patients that receive other type of treatment (non ICD) |
Patients that suffered from MI in the last 3 years and during the enrollment period
|
2차 결과 측정
결과 측정 |
기간 |
|---|---|
|
Study incidence of Arrhythmic mortality and serious arrhythmic events, evaluated through remote monitoring
기간: 5 years (until end 2018)
|
5 years (until end 2018)
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Sergio J Dubner, MD, FACC, Clínica y Maternidad Suizo Argentina and De Los Arcos Sanatorio. Buenos Aires, Argentina
- 수석 연구원: William Uribe, MD, CES Cardiología. Medellin, Colombia
- 연구 의자: Francisco J Alzueta Rodriguez (Study Clinical Advisor), Dr, Hospital Clínico Universitario Virgen de la Victoria. Málaga, Spain
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .